PEAR THERAPEUTICS INC shareholders Q1 2023

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 54 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

PEAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Arboretum Ventures, LLC 10,859,050$2,769,0588.16%
Palantir Technologies Inc. 700,000$178,5001.14%
5AM Venture Management, LLC 16,744,113$4,269,7491.09%
TB Alternative Assets Ltd. 2,071,865$528,3260.13%
EDBI Pte Ltd 427,070$108,9030.12%
Temasek Holdings (Private) Ltd 26,803,573$6,834,9110.04%
SoftBank Group 12,100,078$3,085,5200.04%
Sarissa Capital Management LP 500,356$127,5910.02%
Perceptive Advisors 900,548$229,6390.01%
Legal & General Group Plc 7,198$1,8360.00%
GEODE CAPITAL MANAGEMENT, LLC 1,050,879$267,9740.00%
STATE STREET CORP 1,007,380$256,8820.00%
SG Americas Securities, LLC 84,440$220.00%
PRICE T ROWE ASSOCIATES INC /MD/ 11,499$30.00%
NEW YORK STATE COMMON RETIREMENT FUND 49,215$130.00%
STRS OHIO 47,700$120.00%
DEUTSCHE BANK AG\ 390,623$99,6080.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 120,237$30,6600.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 175,689$44,8010.00%
GOLDMAN SACHS GROUP INC 30,549$7,7900.00%

This page lists PEAR THERAPEUTICS INC's shareholders in Q1 2023. To view PEAR THERAPEUTICS INC's shareholder history, click here.